IMMU-14. IMPLICATIONS FOR T-CELL IMMUNOTHERAPY: CELL SURFACE ANTIGEN AND HLA class I EXPRESSION IN PEDIATRIC BRAIN TUMORS ARE HETEROGENOUS

BACKGROUND: T cells immunotherapy holds the promise to improve outcomes for pediatric brain tumor patients. We have an interest in cell therapy with T cells expressing chimeric antigen receptors (CARs). CAR T cells recognize cell surface antigens. One goal of our study is to evaluate the cell surfac...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Main Authors: Houke, Haley, Baker, Suzanne J, Roussel, Martine F, Gottschalk, Stephen, Krenciute, Giedre
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2019
Assuntos:
Immunology/Immunotherapy
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6477346/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz036.135
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares